Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis

Treatment of juvenile idiopathic arthritis (JIA) with disease-modifying antirheumatic drugs (DMARDs) may improve outcomes compared to conventional therapy (e.g., non-steroidal anti-inflammatory drugs, intraarticular corticosteroids).